brepocitinib (PF-06700841) - Priovant Therap
zasocitinib (TAK-279) - Takeda
AiSuDa (ivarmacitinib) - Jiangsu Hengrui Pharma, Arcutis
tofacitinib - Generic mfg.
itacitinib (INCB039110) - Incyte
ropsacitinib (PF-06826647) - Priovant Therap
Cibinqo (abrocitinib) - Pfizer
Jyseleca (filgotinib) - Gilead
povorcitinib (INCB54707) - Incyte
Jakafi (ruxolitinib) - Incyte
Smyraf (peficitinib) - Astellas, Maruho
Leqselvi (deuruxolitinib) - Sun Pharma
Rinvoq (upadacitinib) - AbbVie
Anzupgo (delgocitinib) - LEO Pharma
gusacitinib (ASN002) - Sanofi
Olumiant (baricitinib) - Eli Lilly
Litfulo (ritlecitinib) - Pfizer
Sotyktu (deucravacitinib) - BMS
http://www.ncbi.nlm.nih.gov/pubmed/42187316
 
András Bánvölgyi; Benedek Nagy; Fanni Adél Meznerics; Karen Krisztina Fazekas; Lajos Vince Kemény; Lili Gulyás; Mária Veronika Kolonics; Máté Krebs; Norbert Kiss; Péter Hegyi; Péter Holló
 
May 27, 2026
 
Prev Next